Investors lose faith in Brazil
Brazil's benchmark Bovespa stockmarket index has fallen by 11% since January to become the world’s worst-performing market.
You would think that soaring energy, mineral and food prices would be good news for a commodity exporter such as Brazil, says Simon Constable in Barron’s. Yet the local stockmarket has been the world’s worst-performing this year. The benchmark Bovespa index has fallen by 11% since 1 January. October marked the fourth losing month in a row for Brazilian stocks, their worst showing since 2014. The real currency has lost 8% against the US dollar so far this year. Economic reform and the commodities boom had tempted in foreign investors, but now “you’ve got a lot of people who are giving up hope”, says Phillip Torres of Aegon Asset Management.
Brazil looks cheap on a cyclically adjusted price/earnings (Cape) ratio of 16.8, according to data from Mebane Faber of Cambria Investment Management. Yet this is no time to go bargain hunting. “A more challenging macro scenario” may see earnings forecasts cut, making currently low valuations deceptive, private banking firm Wealth High Governance tells Bloomberg.
The latest sell-off came as Brazil planned a spending splurge ahead of elections next year. The government of far-right president Jair Bolsonaro wants to spend $14bn on a new welfare programme, a plan that will breach a constitutional spending cap. As Michael Pooler explains in the Financial Times, the cap “limits budget increases in line with inflation and is regarded as a pillar of the country’s economic credibility”. Four senior economic officials have resigned in protest.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Dangerous debt
Brazil can ill-afford a new spending splurge, says Desmond Lachman for The Hill. A Covid-19-induced recession sent the country’s budget deficit up to a record 10% of GDP last year and saw public debt top 100% of GDP. That far exceeds the 70% level that emerging markets try to avoid hitting for fear of “a public debt crisis”. The real’s plunge at a time of “ample global liquidity” is especially worrying; a gradual tightening of US monetary policy means the real’s woes could just be beginning. The independent central bank faces a horrible “dilemma” between “losing control of inflation” and hiking rates to levels that create serious economic pain. It has so far chosen the latter option, raising interest rates 5.75% since March, making it the world’s most hawkish monetary authority.
Bolsonaro’s approval ratings have sunk to new lows, says the Financial Times. A bungled pandemic response has left 600,000 Brazilians dead. He faces a growing thicket of legal investigations, but it is economic mismanagement that may prove “the most potent threat” to his re-election prospects. Never mind the recovery – in Brazil an outright economic contraction may be on the cards next year. “The 2022 elections cannot come quickly enough.”
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Alex Rankine is Moneyweek's markets editor
-
8 of the best houses for sale with wine cellars
The best houses for sale with wine cellars – from a Huguenot townhouse in a conservation area in Spitalfields, London, to a Georgian manor house in Lincoln with a barrel-vaulted wine cellar
By Natasha Langan Published
-
Twenty 'finfluencers' questioned under caution by the UK regulator
The individuals were interviewed voluntarily using the Financial Conduct Authority’s criminal powers
By Chris Newlands Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
Modi’s reforms set Indian stocks on fire
Indian stocks pass a new milestone, but global fund managers are holding back. Are there signs of overheating?
By Alex Rankine Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published